Global Latent Tuberculosis Infection (LTBI) Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Latent Tuberculosis Infection (LTBI) Testing market size was valued at USD 1436.4 million in 2023 and is forecast to a readjusted size of USD 2043.9 million by 2030 with a CAGR of 5.2% during review period.
The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.
Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
The detection industry of latent tuberculosis infection (LTBI) can be subdivided into several parts: tuberculin skin test (TST), interferon release test (IGRA), etc.
Globally, there are mainly Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis infection (LTBI) is an important strategy recognized by the World Health Organization to accelerate the decline of global tuberculosis and achieve the elimination of tuberculosis. Latent tuberculosis infection (LTBI) refers to the state of continuous immune response to the stimulation of Mycobacterium tuberculosis antigen in the absence of clinical evidence of active tuberculosis (TB). The diagnosis and treatment of long-term tuberculosis is very important for tuberculosis, especially for high-risk groups. Tuberculin skin tests (TST) and interferon release tests (IGRAs) were used to diagnose LTBI.
The Global Info Research report includes an overview of the development of the Latent Tuberculosis Infection (LTBI) Testing industry chain, the market status of Hospitals and Clinics (Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA)), Diagnostic Laboratories (Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Latent Tuberculosis Infection (LTBI) Testing.
Regionally, the report analyzes the Latent Tuberculosis Infection (LTBI) Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Latent Tuberculosis Infection (LTBI) Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Latent Tuberculosis Infection (LTBI) Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Latent Tuberculosis Infection (LTBI) Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Latent Tuberculosis Infection (LTBI) Testing market.
Regional Analysis: The report involves examining the Latent Tuberculosis Infection (LTBI) Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Latent Tuberculosis Infection (LTBI) Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Latent Tuberculosis Infection (LTBI) Testing:
Company Analysis: Report covers individual Latent Tuberculosis Infection (LTBI) Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Latent Tuberculosis Infection (LTBI) Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Clinics, Diagnostic Laboratories).
Technology Analysis: Report covers specific technologies relevant to Latent Tuberculosis Infection (LTBI) Testing. It assesses the current state, advancements, and potential future developments in Latent Tuberculosis Infection (LTBI) Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Latent Tuberculosis Infection (LTBI) Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Latent Tuberculosis Infection (LTBI) Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Latent Tuberculosis Infection (LTBI) Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Latent Tuberculosis Infection (LTBI) Testing, with revenue, gross margin and global market share of Latent Tuberculosis Infection (LTBI) Testing from 2019 to 2024.
Chapter 3, the Latent Tuberculosis Infection (LTBI) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Latent Tuberculosis Infection (LTBI) Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Latent Tuberculosis Infection (LTBI) Testing.
Chapter 13, to describe Latent Tuberculosis Infection (LTBI) Testing research findings and conclusion.
The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.
Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
The detection industry of latent tuberculosis infection (LTBI) can be subdivided into several parts: tuberculin skin test (TST), interferon release test (IGRA), etc.
Globally, there are mainly Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis infection (LTBI) is an important strategy recognized by the World Health Organization to accelerate the decline of global tuberculosis and achieve the elimination of tuberculosis. Latent tuberculosis infection (LTBI) refers to the state of continuous immune response to the stimulation of Mycobacterium tuberculosis antigen in the absence of clinical evidence of active tuberculosis (TB). The diagnosis and treatment of long-term tuberculosis is very important for tuberculosis, especially for high-risk groups. Tuberculin skin tests (TST) and interferon release tests (IGRAs) were used to diagnose LTBI.
The Global Info Research report includes an overview of the development of the Latent Tuberculosis Infection (LTBI) Testing industry chain, the market status of Hospitals and Clinics (Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA)), Diagnostic Laboratories (Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Latent Tuberculosis Infection (LTBI) Testing.
Regionally, the report analyzes the Latent Tuberculosis Infection (LTBI) Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Latent Tuberculosis Infection (LTBI) Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Latent Tuberculosis Infection (LTBI) Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Latent Tuberculosis Infection (LTBI) Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Latent Tuberculosis Infection (LTBI) Testing market.
Regional Analysis: The report involves examining the Latent Tuberculosis Infection (LTBI) Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Latent Tuberculosis Infection (LTBI) Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Latent Tuberculosis Infection (LTBI) Testing:
Company Analysis: Report covers individual Latent Tuberculosis Infection (LTBI) Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Latent Tuberculosis Infection (LTBI) Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Clinics, Diagnostic Laboratories).
Technology Analysis: Report covers specific technologies relevant to Latent Tuberculosis Infection (LTBI) Testing. It assesses the current state, advancements, and potential future developments in Latent Tuberculosis Infection (LTBI) Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Latent Tuberculosis Infection (LTBI) Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Latent Tuberculosis Infection (LTBI) Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Tuberculin Skin Test (TST)
- Interferon Gamma Released Assay (IGRA)
- Hospitals and Clinics
- Diagnostic Laboratories
- Others
- Qiagen
- Sanofi
- Oxford Immunotec
- Thermo Fisher Scientific
- Par Sterile
- Bio-Rad Laboratories
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Latent Tuberculosis Infection (LTBI) Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Latent Tuberculosis Infection (LTBI) Testing, with revenue, gross margin and global market share of Latent Tuberculosis Infection (LTBI) Testing from 2019 to 2024.
Chapter 3, the Latent Tuberculosis Infection (LTBI) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Latent Tuberculosis Infection (LTBI) Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Latent Tuberculosis Infection (LTBI) Testing.
Chapter 13, to describe Latent Tuberculosis Infection (LTBI) Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Latent Tuberculosis Infection (LTBI) Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Latent Tuberculosis Infection (LTBI) Testing by Type
1.3.1 Overview: Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type in 2023
1.3.3 Tuberculin Skin Test (TST)
1.3.4 Interferon Gamma Released Assay (IGRA)
1.4 Global Latent Tuberculosis Infection (LTBI) Testing Market by Application
1.4.1 Overview: Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals and Clinics
1.4.3 Diagnostic Laboratories
1.4.4 Others
1.5 Global Latent Tuberculosis Infection (LTBI) Testing Market Size & Forecast
1.6 Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast by Region
1.6.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region, (2019-2030)
1.6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2019-2030)
1.6.6 South America Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Qiagen
2.1.1 Qiagen Details
2.1.2 Qiagen Major Business
2.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.1.4 Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Qiagen Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.2.4 Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Oxford Immunotec
2.3.1 Oxford Immunotec Details
2.3.2 Oxford Immunotec Major Business
2.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.3.4 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Oxford Immunotec Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.4.4 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Par Sterile
2.5.1 Par Sterile Details
2.5.2 Par Sterile Major Business
2.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.5.4 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Par Sterile Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.6.4 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Latent Tuberculosis Infection (LTBI) Testing by Company Revenue
3.2.2 Top 3 Latent Tuberculosis Infection (LTBI) Testing Players Market Share in 2023
3.2.3 Top 6 Latent Tuberculosis Infection (LTBI) Testing Players Market Share in 2023
3.3 Latent Tuberculosis Infection (LTBI) Testing Market: Overall Company Footprint Analysis
3.3.1 Latent Tuberculosis Infection (LTBI) Testing Market: Region Footprint
3.3.2 Latent Tuberculosis Infection (LTBI) Testing Market: Company Product Type Footprint
3.3.3 Latent Tuberculosis Infection (LTBI) Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2030)
6.2 North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2030)
6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
6.3.1 North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2030)
6.3.2 United States Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2030)
7.2 Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2030)
7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
7.3.1 Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
7.3.3 France Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region
8.3.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2019-2030)
8.3.2 China Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
8.3.5 India Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2030)
9.2 South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2030)
9.3 South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
9.3.1 South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
10.3.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Latent Tuberculosis Infection (LTBI) Testing Market Drivers
11.2 Latent Tuberculosis Infection (LTBI) Testing Market Restraints
11.3 Latent Tuberculosis Infection (LTBI) Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Latent Tuberculosis Infection (LTBI) Testing Industry Chain
12.2 Latent Tuberculosis Infection (LTBI) Testing Upstream Analysis
12.3 Latent Tuberculosis Infection (LTBI) Testing Midstream Analysis
12.4 Latent Tuberculosis Infection (LTBI) Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Latent Tuberculosis Infection (LTBI) Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Latent Tuberculosis Infection (LTBI) Testing by Type
1.3.1 Overview: Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type in 2023
1.3.3 Tuberculin Skin Test (TST)
1.3.4 Interferon Gamma Released Assay (IGRA)
1.4 Global Latent Tuberculosis Infection (LTBI) Testing Market by Application
1.4.1 Overview: Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals and Clinics
1.4.3 Diagnostic Laboratories
1.4.4 Others
1.5 Global Latent Tuberculosis Infection (LTBI) Testing Market Size & Forecast
1.6 Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast by Region
1.6.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region, (2019-2030)
1.6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2019-2030)
1.6.6 South America Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Qiagen
2.1.1 Qiagen Details
2.1.2 Qiagen Major Business
2.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.1.4 Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Qiagen Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.2.4 Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Oxford Immunotec
2.3.1 Oxford Immunotec Details
2.3.2 Oxford Immunotec Major Business
2.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.3.4 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Oxford Immunotec Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.4.4 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Par Sterile
2.5.1 Par Sterile Details
2.5.2 Par Sterile Major Business
2.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.5.4 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Par Sterile Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.6.4 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Latent Tuberculosis Infection (LTBI) Testing by Company Revenue
3.2.2 Top 3 Latent Tuberculosis Infection (LTBI) Testing Players Market Share in 2023
3.2.3 Top 6 Latent Tuberculosis Infection (LTBI) Testing Players Market Share in 2023
3.3 Latent Tuberculosis Infection (LTBI) Testing Market: Overall Company Footprint Analysis
3.3.1 Latent Tuberculosis Infection (LTBI) Testing Market: Region Footprint
3.3.2 Latent Tuberculosis Infection (LTBI) Testing Market: Company Product Type Footprint
3.3.3 Latent Tuberculosis Infection (LTBI) Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2030)
6.2 North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2030)
6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
6.3.1 North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2030)
6.3.2 United States Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2030)
7.2 Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2030)
7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
7.3.1 Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
7.3.3 France Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region
8.3.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2019-2030)
8.3.2 China Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
8.3.5 India Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2030)
9.2 South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2030)
9.3 South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
9.3.1 South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
10.3.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Latent Tuberculosis Infection (LTBI) Testing Market Drivers
11.2 Latent Tuberculosis Infection (LTBI) Testing Market Restraints
11.3 Latent Tuberculosis Infection (LTBI) Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Latent Tuberculosis Infection (LTBI) Testing Industry Chain
12.2 Latent Tuberculosis Infection (LTBI) Testing Upstream Analysis
12.3 Latent Tuberculosis Infection (LTBI) Testing Midstream Analysis
12.4 Latent Tuberculosis Infection (LTBI) Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Qiagen Company Information, Head Office, and Major Competitors
Table 6. Qiagen Major Business
Table 7. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 8. Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Qiagen Recent Developments and Future Plans
Table 10. Sanofi Company Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 13. Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Sanofi Recent Developments and Future Plans
Table 15. Oxford Immunotec Company Information, Head Office, and Major Competitors
Table 16. Oxford Immunotec Major Business
Table 17. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 18. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Oxford Immunotec Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Major Business
Table 22. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 23. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Thermo Fisher Scientific Recent Developments and Future Plans
Table 25. Par Sterile Company Information, Head Office, and Major Competitors
Table 26. Par Sterile Major Business
Table 27. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 28. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Par Sterile Recent Developments and Future Plans
Table 30. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 31. Bio-Rad Laboratories Major Business
Table 32. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 33. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Bio-Rad Laboratories Recent Developments and Future Plans
Table 35. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Players (2019-2024)
Table 36. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players (2019-2024)
Table 37. Breakdown of Latent Tuberculosis Infection (LTBI) Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 38. Market Position of Players in Latent Tuberculosis Infection (LTBI) Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 39. Head Office of Key Latent Tuberculosis Infection (LTBI) Testing Players
Table 40. Latent Tuberculosis Infection (LTBI) Testing Market: Company Product Type Footprint
Table 41. Latent Tuberculosis Infection (LTBI) Testing Market: Company Product Application Footprint
Table 42. Latent Tuberculosis Infection (LTBI) Testing New Market Entrants and Barriers to Market Entry
Table 43. Latent Tuberculosis Infection (LTBI) Testing Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value (USD Million) by Type (2019-2024)
Table 45. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Share by Type (2019-2024)
Table 46. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Forecast by Type (2025-2030)
Table 47. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2024)
Table 48. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Forecast by Application (2025-2030)
Table 49. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 50. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 51. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 52. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 53. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 54. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 55. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 58. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 59. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 60. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 61. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 62. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 63. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 64. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 65. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 66. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 67. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 68. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 69. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 70. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 71. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 72. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 74. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 75. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 76. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 77. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 78. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 79. Latent Tuberculosis Infection (LTBI) Testing Raw Material
Table 80. Key Suppliers of Latent Tuberculosis Infection (LTBI) Testing Raw Materials
Table 1. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Qiagen Company Information, Head Office, and Major Competitors
Table 6. Qiagen Major Business
Table 7. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 8. Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Qiagen Recent Developments and Future Plans
Table 10. Sanofi Company Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 13. Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Sanofi Recent Developments and Future Plans
Table 15. Oxford Immunotec Company Information, Head Office, and Major Competitors
Table 16. Oxford Immunotec Major Business
Table 17. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 18. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Oxford Immunotec Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Major Business
Table 22. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 23. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Thermo Fisher Scientific Recent Developments and Future Plans
Table 25. Par Sterile Company Information, Head Office, and Major Competitors
Table 26. Par Sterile Major Business
Table 27. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 28. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Par Sterile Recent Developments and Future Plans
Table 30. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 31. Bio-Rad Laboratories Major Business
Table 32. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 33. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Bio-Rad Laboratories Recent Developments and Future Plans
Table 35. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Players (2019-2024)
Table 36. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players (2019-2024)
Table 37. Breakdown of Latent Tuberculosis Infection (LTBI) Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 38. Market Position of Players in Latent Tuberculosis Infection (LTBI) Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 39. Head Office of Key Latent Tuberculosis Infection (LTBI) Testing Players
Table 40. Latent Tuberculosis Infection (LTBI) Testing Market: Company Product Type Footprint
Table 41. Latent Tuberculosis Infection (LTBI) Testing Market: Company Product Application Footprint
Table 42. Latent Tuberculosis Infection (LTBI) Testing New Market Entrants and Barriers to Market Entry
Table 43. Latent Tuberculosis Infection (LTBI) Testing Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value (USD Million) by Type (2019-2024)
Table 45. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Share by Type (2019-2024)
Table 46. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Forecast by Type (2025-2030)
Table 47. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2024)
Table 48. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Forecast by Application (2025-2030)
Table 49. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 50. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 51. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 52. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 53. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 54. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 55. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 56. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 57. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 58. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 59. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 60. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 61. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 62. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 63. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 64. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 65. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 66. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 67. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 68. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 69. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 70. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 71. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 72. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 73. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 74. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 75. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 76. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 77. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 78. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 79. Latent Tuberculosis Infection (LTBI) Testing Raw Material
Table 80. Key Suppliers of Latent Tuberculosis Infection (LTBI) Testing Raw Materials
LIST OF FIGURES
Figure 1. Latent Tuberculosis Infection (LTBI) Testing Picture
Figure 2. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type in 2023
Figure 4. Tuberculin Skin Test (TST)
Figure 5. Interferon Gamma Released Assay (IGRA)
Figure 6. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application in 2023
Figure 8. Hospitals and Clinics Picture
Figure 9. Diagnostic Laboratories Picture
Figure 10. Others Picture
Figure 11. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Latent Tuberculosis Infection (LTBI) Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Region in 2023
Figure 16. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players in 2023
Figure 22. Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Latent Tuberculosis Infection (LTBI) Testing Market Share in 2023
Figure 24. Global Top 6 Players Latent Tuberculosis Infection (LTBI) Testing Market Share in 2023
Figure 25. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Share by Type (2019-2024)
Figure 26. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Type (2025-2030)
Figure 27. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Share by Application (2019-2024)
Figure 28. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Application (2025-2030)
Figure 29. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 39. France Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Region (2019-2030)
Figure 46. China Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 49. India Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 63. Latent Tuberculosis Infection (LTBI) Testing Market Drivers
Figure 64. Latent Tuberculosis Infection (LTBI) Testing Market Restraints
Figure 65. Latent Tuberculosis Infection (LTBI) Testing Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Latent Tuberculosis Infection (LTBI) Testing in 2023
Figure 68. Manufacturing Process Analysis of Latent Tuberculosis Infection (LTBI) Testing
Figure 69. Latent Tuberculosis Infection (LTBI) Testing Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Latent Tuberculosis Infection (LTBI) Testing Picture
Figure 2. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type in 2023
Figure 4. Tuberculin Skin Test (TST)
Figure 5. Interferon Gamma Released Assay (IGRA)
Figure 6. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application in 2023
Figure 8. Hospitals and Clinics Picture
Figure 9. Diagnostic Laboratories Picture
Figure 10. Others Picture
Figure 11. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Latent Tuberculosis Infection (LTBI) Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Region in 2023
Figure 16. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players in 2023
Figure 22. Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Latent Tuberculosis Infection (LTBI) Testing Market Share in 2023
Figure 24. Global Top 6 Players Latent Tuberculosis Infection (LTBI) Testing Market Share in 2023
Figure 25. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Share by Type (2019-2024)
Figure 26. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Type (2025-2030)
Figure 27. Global Latent Tuberculosis Infection (LTBI) Testing Consumption Value Share by Application (2019-2024)
Figure 28. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Application (2025-2030)
Figure 29. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 39. France Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Region (2019-2030)
Figure 46. China Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 49. India Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Latent Tuberculosis Infection (LTBI) Testing Consumption Value (2019-2030) & (USD Million)
Figure 63. Latent Tuberculosis Infection (LTBI) Testing Market Drivers
Figure 64. Latent Tuberculosis Infection (LTBI) Testing Market Restraints
Figure 65. Latent Tuberculosis Infection (LTBI) Testing Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Latent Tuberculosis Infection (LTBI) Testing in 2023
Figure 68. Manufacturing Process Analysis of Latent Tuberculosis Infection (LTBI) Testing
Figure 69. Latent Tuberculosis Infection (LTBI) Testing Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
